Myogenic commitment of human stem cells by myoblasts Co-culture: a static vs. a dynamic approach

References

• Laumonier T, Menetrey J. Muscle injuries and strategies for improving their repair. J Exp Orthop. 2016;3(1):15.
   PubMedGoogle Scholar
• Fernandes TL, Pedrinelli A, Hernandez AJ. Muscle injury – physiopathology, diagnosis, treatment and clinical presentation. Rev Bras Ortop. 2011;46(3):247–255.
   PubMedGoogle Scholar
• Longo UG, Loppini M, Berton A, et al. Tissue engineered strategies for skeletal muscle injury. Stem Cells Int. 2012;2012:1–9.
   Web of Science ®Google Scholar
• Qazi TH, Duda GN, Ort MJ, et al. Cell therapy to improve regeneration of skeletal muscle injuries. J Cachexia Sarcopenia Muscle. 2019;10(3):501–516.
   PubMed Web of Science ®Google Scholar
• Trucillo E, Bisceglia B, Valdrè G, et al. Growth factor sustained delivery from poly-lactic-co-glycolic acid microcarriers and its mass transfer modeling by finite element in a dynamic and static three-dimensional environment bioengineered with stem cells. Biotechnol Bioeng. 2019;116(7):1777–1794.
   PubMed Web of Science ®Google Scholar
• Ciardulli MC, Marino L, Lamparelli EP, et al. Dose-response tendon-specific markers induction by growth differentiation factor-5 in human bone marrow and umbilical cord mesenchymal stem cells. IJMS. 2020;21(16):5905.
   Google Scholar
• Govoni M, Berardi AC, Muscari C, et al. An engineered multiphase three-dimensional microenvironment to ensure the controlled delivery of cyclic strain and human growth differentiation factor 5 for the tenogenic commitment of human bone marrow mesenchymal stem cells. Tissue Eng Part A. 2017;23(15–16):811–822.
   PubMed Web of Science ®Google Scholar
• Ciardulli MC, Marino L, Lovecchio J, et al. Tendon and cytokine marker expression by human bone marrow mesenchymal stem cells in a hyaluronate/Poly-Lactic-Co-Glycolic acid (PLGA)/fibrin Three-Dimensional (3D) scaffold. Cells. 2020;9(5):1268.
   PubMed Web of Science ®Google Scholar
• Witt R, Weigand A, Boos AM, et al. Mesenchymal stem cells and myoblast differentiation under HGF and IGF-1 stimulation for 3D skeletal muscle tissue engineering. BMC Cell Biol. 2017;18(1):15.
   PubMedGoogle Scholar
• Beier JP, Bitto FF, Lange C, et al. Myogenic differentiation of mesenchymal stem cells co-cultured with primary myoblasts. Cell Biol Int. 2011;35(4):397–406.
   PubMed Web of Science ®Google Scholar
• Ansari S, Chen C, Xu X, et al. Muscle tissue engineering using gingival mesenchymal stem cells encapsulated in alginate hydrogels containing multiple growth factors. Ann Biomed Eng. 2016;44(6):1908–1920.
   PubMed Web of Science ®Google Scholar
• Gunetti M, Tomasi S, Giammò A, et al. Myogenic potential of whole bone marrow mesenchymal stem cells in vitro and in vivo for usage in urinary incontinence. PLoS One. 2012;7(9):e45538.
   PubMed Web of Science ®Google Scholar
• Sisson TH, Nguyen M-H, Yu B, et al. Urokinase-type plasminogen activator increases hepatocyte growth factor activity required for skeletal muscle regeneration. Blood. 2009;114(24):5052–5061.
   PubMed Web of Science ®Google Scholar
• Miller KJ, Thaloor D, Matteson S, et al. Hepatocyte growth factor affects satellite cell activation and differentiation in regenerating skeletal muscle. Am J Physiol Cell Physiol. 2000;278(1):C174–C181.
   PubMed Web of Science ®Google Scholar
• Tonkin J, Temmerman L, Sampson RD, et al. Monocyte/macrophage-derived IGF-1 orchestrates murine skeletal muscle regeneration and modulates autocrine polarization. Mol Ther. 2015;23(7):1189–1200.
   PubMed Web of Science ®Google Scholar
• Kästner S, Elias MC, Rivera AJ, et al. Gene expression patterns of the fibroblast growth factors and their receptors during myogenesis of rat satellite cells. J Histochem Cytochem. 2000;48(8):1079–1096.
   PubMed Web of Science ®Google Scholar
• Conte C, Ainaoui N, Delluc-Clavières A, et al. Fibroblast growth factor 1 induced during myogenesis by a transcription-translation coupling mechanism. Nucleic Acids Res. 2009;37(16):5267–5278.
   PubMed Web of Science ®Google Scholar
• Scala P, Rehak L, Giudice V, et al. Stem cell and macrophage roles in skeletal muscle regenerative medicine. IJMS. 2021;22(19):10867.
   Google Scholar
• Glennie S, Soeiro I, Dyson PJ, et al. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood. 2005;105(7):2821–2827.
   PubMed Web of Science ®Google Scholar
• Ribeiro A, Laranjeira P, Mendes S, et al. Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells. Stem Cell Res. Ther. 2013;4:125.
   PubMed Web of Science ®Google Scholar
• Bach M, Schimmelpfennig C, Stolzing A. Influence of murine mesenchymal stem cells on proliferation, phenotype, vitality, and cytotoxicity of murine Cytokine-Induced killer cells in coculture. PLoS One. 2014;9(2):e88115.
   PubMed Web of Science ®Google Scholar
• Kudlik G, Hegyi B, Czibula Á, et al. Mesenchymal stem cells promote macrophage polarization toward M2b-like cells. Exp Cell Res. 2016;348(1):36–45.
   PubMed Web of Science ®Google Scholar
• El-Sayed M, El-Feky MA, El-Amir MI, et al. Immunomodulatory effect of mesenchymal stem cells: cell origin and cell quality variations. Mol Biol Rep. 2019;46(1):1157–1165.
   PubMed Web of Science ®Google Scholar
• Corcione A, Benvenuto F, Ferretti E, et al. Human mesenchymal stem cells modulate B-cell functions. Blood. 2006;107(1):367–372.
   PubMed Web of Science ®Google Scholar
• Ramasamy R, Fazekasova H, W Lam EF, et al. Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle. Transplantation. 2007;83(1):71–76.
   PubMed Web of Science ®Google Scholar
• Carrier RL, Rupnick M, Langer R, et al. Perfusion improves tissue architecture of engineered cardiac muscle. Tissue Eng. 2002;8(2):175–188.
   PubMedGoogle Scholar
• Lovecchio J, Gargiulo P, Vargas Luna JL, et al. A standalone bioreactor system to deliver compressive load under perfusion flow to hBMSC-seeded 3D chitosan-graphene templates. Sci Rep. 2019;9(1):16854.
   PubMedGoogle Scholar
• Kim J, Ma T. Perfusion regulation of hMSC microenvironment and osteogenic differentiation in 3D scaffold. Biotechnol Bioeng. 2012;109(1):252–261.
   PubMed Web of Science ®Google Scholar
• Lamparelli EP, Lovecchio J, Ciardulli MC, et al. Chondrogenic commitment of human bone marrow mesenchymal stem cells in a perfused collagen hydrogel functionalized with hTGF-β1-Releasing PLGA microcarrier. Pharmaceutics. 2021;13(3):399.
   PubMed Web of Science ®Google Scholar
• Lovecchio J, Pannella M, Giardino L, et al. A dynamic culture platform enhances the efficiency of the 3D HUVEC-based tube formation assay. Biotechnol Bioeng. 2020;117(3):789–797.
   PubMed Web of Science ®Google Scholar
• Pasini A, Lovecchio J, Cortesi M, Liverani C, Spadazzi C, Mercatali L, Ibrahim T, Giordano E. Perfusion Flow Enhances Viability and Migratory Phenotype in 3D-Cultured Breast Cancer Cells. Ann Biomed. Eng. 2021 Sep;49(9):2103–2113. doi: 10.1007/s10439-021-02727-w. Epub 2021 Feb 4. P MID: 33543395; P MCID: P MC8455496.
   PubMed Web of Science ®Google Scholar
• Han TTY, Walker JT, Grant A, et al. Preconditioning human adipose-derived stromal cells on decellularized adipose tissue scaffolds within a perfusion bioreactor modulates cell phenotype and promotes a pro-regenerative host response. Front Bioeng Biotechnol. 2021;9:642465.
   PubMed Web of Science ®Google Scholar
• Ciardulli MC, Lovecchio J, Scala P, et al. 3D biomimetic scaffold for growth factor controlled delivery: an in-vitro study of tenogenic events on Wharton’s jelly mesenchymal stem cells. Pharmaceutics. 2021;13(9):1448.
   PubMed Web of Science ®Google Scholar
• Agrawal G, Aung A, Varghese S. Skeletal muscle-on-a-chip: an in vitro model to evaluate tissue formation and injury. Lab Chip. 2017;17(20):3447–3461.
   PubMed Web of Science ®Google Scholar
• Phan DTT, Wang X, Craver BM, et al. A vascularized and perfused organ-on-a-chip platform for large-scale drug screening applications. Lab Chip. 2017;17(3):511–520.
   PubMed Web of Science ®Google Scholar
• Viswanathan S, Shi Y, Galipeau J, et al. Mesenchymal stem versus stromal cells: international society for cell & gene therapy (ISCT®) mesenchymal stromal cell committee position statement on nomenclature. Cytotherapy. 2019;21(10):1019–1024.
   PubMed Web of Science ®Google Scholar
• Satyavrata Samavedi, Lauren K. Poindexter, Mark Van Dyke and Aaron S. Goldstein. Chapter 7 - Synthetic Biomaterials for Regenerative Medicine Applications, In Regenerative Medicine Applications in Organ Transplantation, edition edited by Giuseppe Orlando, Jan Lerut, Shay Soker and Robert J. Stratta, Academic Press, Boston, 2014. Pages. 81–99, ISBN 9780123985231. https://doi.org/10.1016/B978-0-12-398523-1.00007-0
   Google Scholar
• Pasini A, Lovecchio J, Ferretti G, et al. Medium perfusion flow improves osteogenic commitment of human stromal cells. Stem Cells Int. 2019;(2019):1–10.
   Web of Science ®Google Scholar
• Hellemans J, Mortier G, De Paepe A, et al. qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol. 2007;8(2):R19.
   PubMed Web of Science ®Google Scholar
• Suchorska WM, Lach MS, Richter M, et al. Bioimaging: an useful tool to monitor differentiation of human embryonic stem cells into chondrocytes. Ann Biomed Eng. 2016;44(5):1845–1859.
   PubMed Web of Science ®Google Scholar
• de Winter J.C.F. (2013) “Using the Student’s t-test with extremely small sample sizes,” Practical Assessment, Research, and Evaluation: Vol. 18 , Article 10. DOI: https://doi.org/10.7275/e4r6-dj05
   Google Scholar
• Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy. 2006;8(4):315–317.
   PubMed Web of Science ®Google Scholar
• Bentzinger CF, Wang YX, Rudnicki MA. Building muscle: molecular regulation of myogenesis. Cold Spring Harb Perspect. Biol. 2012;4(2):a008342–a008342.
   PubMed Web of Science ®Google Scholar
• Plotnikov EY, Khryapenkova TG, Vasileva AK, et al. Cell-to-cell cross-talk between mesenchymal stem cells and cardiomyocytes in co-culture. J Cell Mol Med. 2008;12(5A):1622–1631.
   PubMed Web of Science ®Google Scholar
• Liu X, Chen W, Zhang C, et al. Co-seeding human endothelial cells with human-induced pluripotent stem cell-derived mesenchymal stem cells on calcium phosphate scaffold enhances osteogenesis and vascularization in rats. Tissue Eng Part A. 2017;23(11–12):546–555.
   PubMed Web of Science ®Google Scholar
• Asfour HA, Allouh MZ, Said RS. Myogenic regulatory factors: the orchestrators of myogenesis after 30 years of discovery. Exp Biol Med. 2018;243(2):118–128.
   Web of Science ®Google Scholar
• Shang YC, Zhang C, Wang SH, et al. Activated beta-catenin induces myogenesis and inhibits adipogenesis in BM-derived mesenchymal stromal cells. Cytotherapy. 2007;9(7):667–681.
   PubMed Web of Science ®Google Scholar
• Kozlowska U, Krawczenko A, Futoma K, et al. Similarities and differences between mesenchymal stem/progenitor cells derived from various human tissues. World J Stem Cells. 2019;11(6):347–374.
   PubMed Web of Science ®Google Scholar
• Chen S-E, Jin B, Li Y-P. TNF-alpha regulates myogenesis and muscle regeneration by activating p38 MAPK. Am J Physiol Cell Physiol. 2007;292(5):C1660–C1671.
   PubMed Web of Science ®Google Scholar
• Li Y-P, Schwartz RJ. TNF-alpha regulates early differentiation of C2C12 myoblasts in an autocrine fashion. Faseb J. 2001;15(8):1413–1415.
   PubMedGoogle Scholar
• Li Y-P. TNF-alpha is a mitogen in skeletal muscle. Am J Physiol Cell Physiol. 2003;285(2):C370–C376.
   PubMed Web of Science ®Google Scholar
• Zhao Q, Yang ST, Wang JJ, et al. TNF alpha inhibits myogenic differentiation of C2C12 cells through NF-κB activation and impairment of IGF-1 signaling pathway. Biochem Biophys Res Commun. 2015;458(4):790–795.
   PubMed Web of Science ®Google Scholar
• Grabiec K, Tokarska J, Milewska M, et al. Interleukin-1beta stimulates early myogenesis of mouse C2C12 myoblasts: the impact on myogenic regulatory factors, extracellular matrix components, IGF binding proteins and protein kinases. Pol J Vet Sci. 2013;16(2):255–264.
   PubMed Web of Science ®Google Scholar
• Li W, Moylan JS, Chambers MA, et al. Interleukin-1 stimulates catabolism in C2C12 myotubes. Am J Physiol Cell Physiol. 2009;297(3):C706–C714.
   PubMed Web of Science ®Google Scholar
• Deng B, Wehling-Henricks M, Villalta SA, et al. IL-10 triggers changes in macrophage phenotype that promote muscle growth and regeneration. J Immunol. 2012;189(7):3669–3680.
   PubMed Web of Science ®Google Scholar
• Horsley V, Jansen KM, Mills ST, et al. IL-4 acts as a myoblast recruitment factor during mammalian muscle growth. Cell. 2003;113(4):483–494.
   PubMed Web of Science ®Google Scholar
• Chang Y-H, Tsai J-N, Chen T-L, et al. Interleukin-4 promotes myogenesis and boosts myocyte insulin efficacy. Mediators Inflamm. 2019;(2019):1–14.
   Web of Science ®Google Scholar